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Abstract
Background: Bacterial burn infections are one of the serious infections and since their treatment with antibiotics is very difficult,
infection control in such wounds is very important. Therefore, methods should be sought to enhance the effects of antibiotics and
also reduce the resistance to them. It seems that probiotics have antimicrobial features and are effective in wound healing.
Objectives: The current study aimed at evaluating and comparing the antimicrobial effects of antibiotics and probiotics, as well as
their combination on bacterial burn infections.
Methods: Thirty clinically resistant Pseudomonas aeruginosa species isolated from hospitalized patients with burn wounds were col-
lected. Antibacterial activity of five antibiotics and 11 probiotic strains, and also their combination were evaluated by disk diffusion
method. One-way ANOVA and Tukey post hoc test were used for data analysis.
Results: It was found that the effect of inhibitory zone in combination use of tetracycline + a probiotic strain was more than us-
ing the antibiotic and probiotic alone. Also, the current study found that among the probiotics, Lactobacillus plantarum 299v had
the highest effect, although not significant, on resistant P. aeruginosa. The current study explained that the inhibitory effect of L.
plantarum 299v was significantly higher than that of ciprofloxacin (P = 0.009). In addition, antibacterial activity of gentamicin + L.
salivarius (ES1) was significantly higher compared with that of gentamicin + L. routeri (P = 0.01).
Conclusions: The current study explained that probiotics had a useful potential inhibitory effect on the growth of the pathogens.
The study showed that in most cases, inhibitory zones of probiotics were greater than those of antibiotics as well as combination
of antibiotic + probiotic. But, there was an exception in tetracycline, which had synergistic effect with probiotics. Conversely, in the
cases of imipenem and chloramphenicol, addition of probiotics had antagonistic effects. Further studies are needed to describe
different results. Therefore, it seems that the type of antibiotics and probiotics are important to create the synergistic or antagonistic
effects.
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1. Background
Pseudomonas aeruginosa is a Gram-negative, oppor-
tunistic human pathogen (1). The use of therapeutic so-
lutions to control or reduce resistance in P. aeruginosa is
one of the important cases recently raised attentions, es-
pecially in burn injuries (2). Also, the prevalence of resis-
tant pathogens creates problems to treat the infection in
patients. In fact, this problem created major concerns in
the medical societies (1, 3). Patients with burn injuries are
at high risk for nosocomial infections. Hence, the control
of antibiotic resistance can be one of the main strategies
to prevent multidrug-resistance (MDR) infections (4). In
recent years, the role of probiotics is confirmed to control
burn infections. These materials produce vitamin B, lactic
acid, hydrogen peroxide, and acetic acid that play the im-
portant role in the inhibition of the growth of pathogenic
bacteria (1, 5). In other words, probiotic strains are the best
alternative treatment for the infectious diseases (6). In this
regard, a number of studies show the inhibitory effect of
Lactobacillus strains on the growth of the resistant strains
of Pseudomonas aeruginosa (7-9). Some studies reported
that extracellular products of lactic acid bacteria and Bifi-
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dobacterium species can inhibit the growth of pathogenic
microorganisms and they contribute to burn wounds heal-
ing (10).
The consumption of antibiotics commonly used to
treat the infectious diseases can reduce the protection of
beneficial bacteria in gastrointestinal tract, leading to sev-
eral diseases (11). Thus, application of probiotics can re-
store the normal intestinal flora and inhibit the growth of
harmful bacteria. Also, a combination of antibiotics and
probiotics may compensate and minimized the complica-
tions caused by the antibiotics (2).
2. Objectives
The current study aimed at evaluating the an-
timicrobial effects of antibiotics including imipenem,
ciprofloxacin, chloramphenicol, gentamicin and tetracy-
cline, and those of some probiotics including L. salivarius,
L. reuteri, L. acidophilus, Bacillus coagulans, L. plantarum, and
Bifidobacterium bifidum, as well as their combinations (pro-
biotics + antibiotics) against MDR P. aeruginosa isolated
from burn wounds.
3. Methods
3.1. Collection and Isolation of Pathogens
The current study was conducted from November 2015
to December 2016. Thirty MDR isolates of P. aeruginosa
were clinically isolated from patients with burn wounds
within 10 - 15 days. The patients were selected from Tehran
Motahari hospital affiliated to Iran University of Medical
Sciences. The isolates were transferred to the microbiol-
ogy laboratory of antimicrobial resistance research cen-
ter to approve the identification of P. aeruginosa. Samples
were cultured on MacConkey agar, incubated under aero-
bic conditions for 24 - 36 hours at 37°C (3). The isolated bac-
teria were identified based on colony morphology, micro-
scopic Gram stain investigation, and standard biochemical
tests (3).
3.2. Antimicrobial Testing
The sensitivity of samples was determined by disk dif-
fusion method using Mueller-Hinton agar according to the
clinical and laboratory standards institute (CLSI, 2016) rec-
ommendations. In the current study, the following five an-
tibiotic disks (Mast Group Ltd., Merseyside, UK) were used:
imipenem (10 µg), gentamicin (10 µg), chloramphenicol
(30 µg), ciprofloxacin (30 µg), and tetracycline (30 µg). In
the current study, the reference strain P. aeruginosa ATCC
27853 was used for quality control (12). For this purpose,
the bacterial suspension (0.5 McFarland) were cultured on
Mueller-Hinton agar plates and then antibiotic discs were
placed on the medium and incubated at 37°C for 16 hours
(1). Among the thirty MDR strains of P. aeruginosa, four
isolates that showed the highest antimicrobial resistance
were selected. Highest resistance (small inhibitory zone)
was examined based on the zone diameters.
3.3. Preparation and Cultivation of Probiotic Bacteria
In the current study, 11 probiotic strains were taken
from probiotic research center of Alborz University of Med-
ical Sciences, five commercial probiotic strains were pur-
chased from DSM and six local Lactobacillus strains were
isolated from broiler feces of tropical area of Iran by agri-
cultural biotechnology research institute of iran (ABRII)
and identified based on biochemical tests and 16s RNA as
described previously (3). The commercial probiotic strains
included L. Reuteri (DSM17938), L. acidophilus (DSM), B. co-
agulans (DSM1), L. plantarum 299v (DSM9843), and B. bi-
fidum (DSM20456). The local Lactobacillus strains included
L. reuteri and L. salivarius. Probiotics were cultured in MRS
broth, a selective medium for profuse growth of lactic
acid bacteria, and incubated under anaerobic conditions
at 37°C for 48 - 72 hours (13). Then, they were transferred to
MRS agar (Merck, Darmstadt, Germany). Finally, probiotics
were aseptically frozen at -4°C for two weeks.
3.4. Antibacterial Activity of Probiotic Strains Against
Pathogens
Antibacterial activity of all the 11 probiotic strains was
tested separately against four isolates of P. aeruginosa. An-
timicrobial resistant samples were examined using pre-
viously probiotic-coated discs. Probiotic-coated discs ob-
tained using the below-mentioned protocol. probiotics
were cultured on MRS broth (0.5 McFarland standards),
then 20 γ (mL) of probiotic suspension was added to the
blank disc and placed on a Muller-Hinton agar medium
and incubated at 37°C for 16 hours (1, 7).
3.5. Combination Method
In the above sections, the antibacterial activity of an-
tibiotic disks and the mentioned probiotic strains were
separately investigated. In this section, the antibacterial
activity of antibiotic and probiotic strains was tested sep-
arately. In the combination method, four P. aeruginosa
isolates were cultured separately on Muller-Hinton agar
plates. Twenty milliliters of each 11 probiotic suspensions
were added to the five antibiotics discs separately. Then,
the plates were incubated at 37°C for 16 hours. The in-
hibitory zone diameters were measured and recorded.
2 Arch Clin Infect Dis. 2018; 13(3):e63121.
Soleymanzadeh Moghadam S et al.
3.6. Statistical Analysis
The SPSS version 20 as well as Excel 2010 was employed
for statistical analysis using One-way ANOVA and Tukey
post hoc test.
4. Results
In the current study, the effects of 11 probiotic strains
were measured against resistant pathogenic isolates. The
antimicrobial activity of these probiotic strains against P.
aeruginosa isolates were shown as mean diameter of in-
hibitory zones. As shown in Figure 1 among the probiotic
strains, L. plantarum 299v had the highest mean inhibitory
diameter against MDR strains of P. aeruginosa. Among the
MDR isolates of P. aeruginosa, those sensitive to eight pro-
biotic strains were selected (Figure 1).
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Figure 1. The effect of 11 probiotic strains against resistant P. aeruginosa isolates; L.
plantarum 299v had the maximum mean inhibitory zone diameter (but not signifi-
cantly) against resistant P. aeruginosa
Antibacterial activities of the mentioned probiotics
and antibiotics alone and in-combination forms against
P. aeruginosa were examined by measurement of their in-
hibitory zones. The results are illustrated in Figure 2.
The current study found that antibacterial activity of
probiotic strains was more than that of antibiotics. The
antibacterial activity was examined by measurement in-
hibition zones (Figure 2). The current study showed that
the mean diameter of inhibitory zones in the combination
form of tetracycline + probiotics was higher than that of
tetracycline or probiotics alone, although the difference
was statistically insignificant. And also in most cases, the
antibacterial activities of probiotics were more than those
of antibiotics alone. Antibacterial activities of probiotics
were more than those of antibiotics alone and the com-
bination form, especially ciprofloxacin (Figure 2). Among
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Figure 2. The antibacterial activity of probiotics and antibiotics alone and in-
combination against P. aeruginosa isolates based on the inhibitory zones diameter.
Tetracycline (TET), imipenem (IM), ciprofloxacin (CIP), chloramphenicol (CL), gen-
tamicin, probiotic (P).
these findings, the effect of L. plantarum 299v was signifi-
cantly higher than that of ciprofloxacin (P = 0.009). In ad-
dition, antibacterial activity of gentamicin + L. salivarius
(ES1) was significantly higher than that of gentamicin + L.
routeri (P = 0.01).
5. Discussion
The current study aimed at evaluating the antimicro-
bial activity of selected antibiotics and probiotics as well
as their combinations against MDR P. aeruginosa isolated
from burn wounds. The current study showed that the
mean diameter of the inhibitory zone of probiotics was
greater than that of antibiotics. The same result was re-
ported from a similar study on P. aeruginosa conducted
by Chauhan who showed that in about 72% of the cases,
inhibitory zones of probiotics were greater than those of
antibiotics (5). There are several mechanisms to justify
the protective and therapeutic effects of probiotics includ-
ing production of antimicrobial agents, pathogen elimi-
nation, and immunomodulation (2, 14, 15). Also, it was re-
ported that in half of the cases, the efficacy of a combina-
tion from of probiotics plus antibiotics was higher than
that of antibiotics alone (2). In the current study, the effects
of probiotics alone in most cases -except in combination
with the tetracycline- were better than those of the probi-
otic +antibiotic and antibiotic alone (Figure 2). Therefore,
laboratory results of the current study showed that Lacto-
bacillus strains increased the inhibitory zone of P. aerugi-
nosa, compared with those of antibiotics, except tetracy-
cline. Probiotic strains -including L. salivarius, L. reuteri,
L. acidophilus, B. coagulans, L. plantarum, and B. bifidum-
alone or in combination with pathogens had considerable
effects (16). Findings related to tetracycline were totally
different from those of other antibiotics. In fact, among
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the five antibiotics employed in the current study, tetracy-
cline had synergistic effect with probiotics. In other sim-
ilar studies, synergistic effect was observed in the com-
bination of doxycycline and probiotics (7, 17). Also, in a
study on urinary tract and nosocomial infections, it was
observed that the diameter of the growth inhibition zone
of P. aeruginosa in combination with probiotics and aztre-
onam was higher than those of ciprofloxacin, meropenem,
and amikacin separately. Actually, it was determined that
there was synergistic effect between aztreonam and probi-
otics (2, 17).
Therefore, it seems that the type of antibiotic and pro-
biotic is important in creating the synergistic or antagonis-
tic effects. In this regard, the differences in the mechanism
of action of antibiotics are important. For example, doxy-
cycline by binding to the bacterial ribosome subunit 30s
inhibits the protein synthesis. Therefore, when antibiotic
is used separately, the pathogen tolerates in the situation
better than the combination forms of antibiotics plus pro-
biotics. Probiotics increase the penetration rate and pro-
vide higher sensitivity (3). Therefore, probiotic strains can
be used to support the potency of antibiotics against bac-
terial pathogens (7). In the current study, for the first time,
it was reported that tetracycline had higher effects both in
combination and alone on MDR P. aeruginosa isolated from
burn wounds.
For example, it was observed that antibacterial activ-
ity of L. plantarum was significantly higher than that of
ciprofloxacin (P = 0.009), which was confirmed in simi-
lar studies reporting that the combination of L. acidophilus
and ciprofloxacin had better effects than antibiotics alone
(5, 18, 19). In addition, it was found that the mean diameter
of growth inhibition zone of the pathogen using a combi-
nation of gentamicin + L. salivarius (ES 1) was significantly
higher than that of the combination of gentamicin + L.
routeri (P = 0.01), indicating the advantage of combination
of gentamicin + L. salivarius compared with gentamicin +
L. routeri (5). In the case of antagonistic effects of probi-
otics on antibiotics, the current study observed that addi-
tion of probiotics to imipenem and chloramphenicol had
negative effects and reduced the inhibitory zones. How-
ever, these results were obtained from in vitro studies, and
further in vivo studies are suggested regarding different
strains of probiotics and antibiotics in infections caused by
MDR pathogens.
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